Back to Search
Start Over
Prime Medicine Receives Up to $15 Mn from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGEtm Prime Editors for Cystic Fibrosis
- Source :
- Plus Company Updates. January 27, 2024
- Publication Year :
- 2024
-
Abstract
- CAMBRIDGE: Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that the Cystic Fibrosis Foundation (CF Foundation) [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.782008999